Physician profile
Jay M Straight
NPI 1326121237
$783.55
in general payments reported to CMS, 2019-2025
16 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2022: $50.20 · 2023: $13.13 · 2024: $212 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $143.46 | 2019-2025 | Airsupra, Nexium, Breztri |
| Viiv Healthcare Company | $111.40 | 2022-2025 | Apretude |
| Otsuka America Pharmaceutical, INC. | $100.20 | 2024-2025 | Rexulti |
| Abbvie INC. | $92.89 | 2019-2025 | |
| Glaxosmithkline, LLC. | $54.10 | 2024-2025 | Arexvy, Shingrix |
| Exact Sciences Corporation | $51.78 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $37.09 | 2024-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $33.94 | 2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $26.29 | 2019 | |
| Gilead Sciences, INC. | $25.76 | 2025 | Yeztugo |
| Alkermes, INC. | $24.29 | 2024 | Vivitrol |
| Lucid Diagnostics INC. | $22.44 | 2022 | |
| Shire North American Group INC | $16.89 | 2019 | |
| Eisai INC. | $16.55 | 2025 | |
| Alexion Pharmaceuticals, INC. | $13.46 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $13.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Straight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.